Literature DB >> 17261807

Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9.

Peggy Parroche1, Fanny N Lauw, Nadege Goutagny, Eicke Latz, Brian G Monks, Alberto Visintin, Kristen A Halmen, Marc Lamphier, Martin Olivier, Daniella C Bartholomeu, Ricardo T Gazzinelli, Douglas T Golenbock.   

Abstract

Hemozoin (HZ) is an insoluble crystal formed in the food vacuole of malaria parasites. HZ has been reported to induce inflammation by directly engaging Toll-like receptor (TLR) 9, an endosomal receptor. "Synthetic" HZ (beta-hematin), typically generated from partially purified extracts of bovine hemin, is structurally identical to natural HZ. When HPLC-purified hemin was used to synthesize the crystal, beta-hematin had no inflammatory activity. In contrast, natural HZ from Plasmodium falciparum cultures was a potent TLR9 inducer. Natural HZ bound recombinant TLR9 ectodomain, but not TLR2. Both TLR9 stimulation and TLR9 binding of HZ were abolished by nuclease treatment. PCR analysis demonstrated that natural HZ is coated with malarial but not human DNA. Purified malarial DNA activated TLR9 but only when DNA was targeted directly to the endosome with a transfection reagent. Stimulatory quantities of natural HZ contain <1 microg of malarial DNA; its potency in activating immune responses was even greater than transfecting malarial DNA. Thus, although the malarial genome is extremely AT-rich, its DNA is highly proinflammatory, with the potential to induce cytokinemia and fever during disease. However, its activity depends on being bound to HZ, which we propose amplifies the biological responses to malaria DNA by targeting it to a TLR9(+) intracellular compartment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261807      PMCID: PMC1794278          DOI: 10.1073/pnas.0608745104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites.

Authors:  Ricardo T Gazzinelli; Catherine Ropert; Marco A Campos
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

2.  An alternative to serum for cultivation of Plasmodium falciparum in vitro.

Authors:  S L Cranmer; C Magowan; J Liang; R L Coppel; B M Cooke
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 May-Jun       Impact factor: 2.184

3.  Patterns of haemozoin accumulation in tissue.

Authors:  A D Sullivan; I Ittarat; S R Meshnick
Journal:  Parasitology       Date:  1996-03       Impact factor: 3.234

4.  On the molecular mechanism of chloroquine's antimalarial action.

Authors:  D J Sullivan; I Y Gluzman; D G Russell; D E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment).

Authors:  T J Egan; D C Ross; P A Adams
Journal:  FEBS Lett       Date:  1994-09-19       Impact factor: 4.124

6.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta.

Authors:  S Pichyangkul; P Saengkrai; H K Webster
Journal:  Am J Trop Med Hyg       Date:  1994-10       Impact factor: 2.345

9.  Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo.

Authors:  B A Sherry; G Alava; K J Tracey; J Martiney; A Cerami; A F Slater
Journal:  J Inflamm       Date:  1995

10.  Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.

Authors:  Sathit Pichyangkul; Kosol Yongvanitchit; Utaiwan Kum-arb; Hiroaki Hemmi; Shizuo Akira; Arthur M Krieg; D Gray Heppner; V Ann Stewart; Hitoshi Hasegawa; Sornchai Looareesuwan; G Dennis Shanks; R Scott Miller
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

View more
  232 in total

1.  Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells.

Authors:  N W Lucchi; D Sarr; S O Owino; S M Mwalimu; D S Peterson; J M Moore
Journal:  Placenta       Date:  2011-05-31       Impact factor: 3.481

2.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

3.  Genetic predisposition of variants in TLR2 and its co-receptors to severe malaria in Odisha, India.

Authors:  Subhendu Panigrahi; Avishek Kar; Sagnika Tripathy; Manoj K Mohapatra; Gunanidhi Dhangadamajhi
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

4.  Cyclic GMP-AMP Synthase Is the Cytosolic Sensor of Plasmodium falciparum Genomic DNA and Activates Type I IFN in Malaria.

Authors:  Carolina Gallego-Marin; Jacob E Schrum; Warrison A Andrade; Scott A Shaffer; Lina F Giraldo; Alvaro M Lasso; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

5.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

6.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

7.  Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.

Authors:  Bernardo S Franklin; Peggy Parroche; Marco Antonio Ataíde; Fanny Lauw; Catherine Ropert; Rosane B de Oliveira; Dhelio Pereira; Mauro Shugiro Tada; Paulo Nogueira; Luiz Hildebrando Pereira da Silva; Harry Bjorkbacka; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

9.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 10.  Immune escape by Epstein-Barr virus associated malignancies.

Authors:  Christian Münz; Ann Moormann
Journal:  Semin Cancer Biol       Date:  2008-10-19       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.